Skip to main content

Amplity Insights’ Discontinuation Report Named One of the Most Innovative Services of 2022 by PM360


The Discontinuation Report, fueled by the Amplity Insights database, was selected by PM360 amongst hundreds of submissions from across the healthcare and life sciences industries.

Langhorne, PA - Amplity Health, a leading global medical and commercial partner to biopharmaceutical companies, today announced that PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, named Amplity Insights’ Discontinuation Report as one of the most innovative services of 2022.

The Discontinuation Report was created to bring a new perspective and a much broader understanding of how patients are diagnosed and treated. By leveraging data from Amplity Insights, a provider of medical data sets mined from unstructured text transcriptions of patient–physician interactions, the report provides real-world data to inform questions like:

  • Why are providers choosing to discontinue use of competitive drugs?
  • Which marketing messages will best resonate with targeted HCPs?
  • What are the factors influencing HCPs to recommend one treatment over another?
  • Which factors—cost, side effects, etc.—prevent patients from staying on script?

Joe Turner, Head of Amplity Insights, explains, “We designed the Discontinuation Report to provide answers to the questions our pharmaceutical clients are struggling to answer. It’s been incredibly rewarding to witness the progress our Clinical, Commercial, HEOR, and Data and Analytics clients have been able to make following the delivery of the Discontinuation Report.”

Amplity Insights’ Discontinuation Report was selected as part of PM360’s 11th Annual Innovations Issue published each December. This issue was established to serve as a guide to the year’s most innovative companies, startups, divisions, products, services, and strategies from within the healthcare and life sciences industries. This comprehensive overview of the year’s most innovative achievements in these 6 categories helps other companies in the industry to find potential partners and offerings that can help them advance healthcare and life sciences.

“Our goal for this year’s edition of our annual Innovations Issue was to highlight those in our industry who continue to think big as we emerge from the impact of the pandemic,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “Each of this year’s selections fulfills that goal by delivering big ideas that are resulting in exciting developments across the industry, which can include new therapies, healthcare technology, marketing solutions, clinical trial programs, methods to boost adherence, and much more.”

PM360 received hundreds of submissions from across the healthcare and life sciences industries. The editorial staff of PM360 evaluated each submission and selected their picks for the most innovative, regardless of category. Ultimately, 46 total innovations were featured in the issue. Within the Service category, a total of 6 services were featured. All of this year’s selections can be found at


About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision-making, including planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing a full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.


About the Amplity Insights Database

Amplity Insights’ database of medical transcription records provides a unique perspective on patient conditions and provider interactions. This robust database offers access to HEOR studies, patient journey reports, provider targeting lists, and beyond. Using our proprietary Natural Language Processing (NLP) algorithms, meaningful data end points may be quickly extracted and evaluated for specific research questions. Leveraging this rich source of patient-level data, researchers are able to glean insights related to the true prevalence of disease, treatment patterns, rationale for treatment, and patient-reported outcomes. Visit to learn more.


About Amplity Health

The true partner of global healthcare companies, Amplity Health delivers tailored medical and commercial solutions that scale throughout the life cycle of your drug. Amplity is a global authority in scientific stakeholder engagement, go-to-market strategies, and is built upon our belief in the power of face-to-face interaction that nurtures trust with physicians, patients, and payers, allowing for the exchange of complex ideas. We are proud of our inclusive culture and our EPIIC values. Amplity has the expertise, global infrastructure, and data-driven insights to help clients overcome their medical and commercial challenges. Amplity’s wide-ranging capabilities include clinical and medical outsourced teams; clinical and medical capability development; companion diagnostic and precision medicine solutions; medical communications; expert engagement; remote and field solutions for patients, payers, and physicians; and strategic and access consulting. Amplity’s one-of-a-kind Insights database offers clients a detailed view into patient–provider interactions and provider treatment rationale not found through any other provider. For more information, visit Connect with Amplity on Twitter and LinkedIn. Amplity Health is a portfolio company of Altamont Capital Partners.


About Altamont Capital Partners

Altamont Capital Partners is a private investment firm based in the San Francisco Bay Area with more than $3.5 billion of assets under management. Altamont is focused on investing in middle market businesses where it can partner with leading management teams to help its portfolio companies reach their full potential. The firm’s principals have significant experience building business success stories across a range of industries, including healthcare, business services, financial services, consumer/retail, and industrials.